World Epilepsy Drug Market - Opportunities and analysis with key players Pfizer, Inc., Eisai Co., Ltd, Novartis AG, Sanofi S.A., UCB S.A., Abbott Laboratories, GlaxoSmithKline plc, Sunovion Pharmaceuticals Inc. and Teva Pharmaceutical Industries Ltd.

Epilepsy is a chronic brain disorder characterized by sudden and recurrent episodes of seizure. It is one of the most common neurological disorders worldwide, affecting people of all ages. Presently, around 50 million patients are living with epilepsy worldwide and about 2.4 million new cases are diagnosed annually. Moreover, majority of the epileptic cases are idiopathic, with no identifiable cause. At present, only symptomatic treatment through medication, surgery and implantable devices, is available, but there is no cure for epilepsy. This highlights the untapped market need for better therapeutics which would provide lucrative growth opportunities to industry players.

Rising incidence of neurological disorders, higher incidence of birth related injuries, increasing road traffic injuries, growing disease awareness and rising patient base in developing countries, are the significant factors driving the global Epilepsy drug market. Moreover, increasing R&D investment and launch of extended-release formulations are further expected to fuel the market growth. However, high cost of patented drugs and low accessibility to Epilepsy drugs in low and middle income countries, are likely to restrict the market growth.

Get sample cop of this report at:
https://www.alliedmarketresearch.com/request-toc-and-sample/1497

The global epilepsy drug market is segmented on the basis of drug type and geography. On the basis of drug type, the market is segmented into marketed drugs and pipeline drugs. The market, on the basis of marketed drugs is further segmented into first generation drugs (Phenytoin, Carbamazepine, Oxycarbazepine), second generation drugs (Levetiracetam, Lamotrigine, Topiramate) and third generation drugs (Lacosamide, Perampanel, Eslicarbazepine Acetate). Geographically, the market is segmented across four regions namely North America, Europe, Asia Pacific and LAMEA.

KEY MARKET BENEFITS:

• Comprehensive analysis of factors that drive and restrict the growth of the global epilepsy drug market is provided

• The report provides a comprehensive analysis of the current market and estimations through 20142020, which would enable the stakeholders to capitalize on prevailing market opportunities

• Extensive analysis of the global epilepsy drug market on the basis of drug type helps in understanding the types of drugs that are currently used along with the variants that would gain prominence in future

• SWOT analysis highlights the internal environment of the leading companies for strategy formulation

• Region-wise epilepsy drug market conditions are comprehensively analysed in the report

• Competitive intelligence highlights the business practises followed by leading market players across geographies

Get customized copy of this report at:
https://www.alliedmarketresearch.com/request-for-customization/1497

Epilepsy Drug Market By Drug Type:

• Marketed Drugs
o First Generation Drugs
 Phenytoin
 Carbamazepine
 Oxycarbazepine
 Valproate
 Ethosuximide
 Primidone
 Phenobarbital

o Second Generation Drugs
 Levetiracetam
 Lamotrigine
 Topiramate
 Pregabalin
 Rufinamide
 Zonisamide

Major key players:

• Pfizer Inc.
• Eisai Co.Ltd
• Novartis AG
• Sanofi S.A.
• UCB S.A.
• Abbott Laboratories
• GlaxoSmithKline plc
• Sunovion Pharmaceuticals Inc.
• Teva Pharmaceutical Industries Ltd.

Access full summary if this report at:
https://www.alliedmarketresearch.com/epilepsy-drug-market

About Us:

Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
Sona Padman
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1?855?550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.